Follow
Share

"Early diagnosis really does make a difference now in terms of changing the trajectory of someone's cognitive health.” — Gayatri Devi
The evolution of Alz disease and dementia care: Re: early detection, personalized treatment, new therapies, and a multimodal approach.by Peter Attia
“Gayatri Devi is a nationally recognized neurologist specializing in memory disorders, including Alzheimer’s disease and related dementias. In this episode, Gayatri explains how to think about dementia as a spectrum—including Alzheimer’s disease, vascular dementia, Lewy body dementia, and mixed presentations—while exploring the evolving biology of amyloid, tau, and neuroinflammation and why brain pathology does not always correlate with symptoms. She discusses her approach to detecting subtle cognitive decline in high-functioning individuals, the role of biomarkers and APOE4 testing in asymptomatic patients, the benefits and risks of anti-amyloid therapies such as lecanemab and donanemab, and strategies for minimizing treatment-related complications. Gayatri also examines why some patients may stabilize or even improve with individualized care, the overlap among different dementia syndromes, and the relationship between menopause, estrogen, and cognition—including her concept of menopause-related cognitive impairment. Finally, she discusses how advances in early detection, AI-assisted monitoring, targeted therapies, and precision medicine are reshaping the future of dementia care.”
This is a very interesting conversation. ALz, Parkinson’s, Lewy Body’s, Vascular, Menopause, etc. many things our posters are dealing with and caregivers may be concerned about with their own health.

https://peterattiamd.com/gayatridevi/?utm_source=Klaviyo&utm_medium=campaign&utm_campaign=260713%20-%20Gayatri%20Devi%20-%20Subs&_kx=46m6-UQzMOHQzo840GEKz5UoxM_vH_06nt1T00CamR4.W9ibUh
you can find this on YouTube as well.

Find Care & Housing
Start a Discussion
Subscribe to
Our Newsletter